Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
As activated hepatic stellate cells and liver sinusoidal endothelial cells express high levels of integrin α v β3, Turaga et al. present a strategy for treatment of chronic liver disease using their rationally designed protein (ProAgio) which targets integrin α v β3. They find that ProAgio –mediated...
Guardado en:
Autores principales: | Ravi Chakra Turaga, Ganesh Satyanarayana, Malvika Sharma, Jenny J. Yang, Shiyuan Wang, Chunfeng Liu, Sun Li, Hua Yang, Hans Grossniklaus, Alton Brad Farris, Jordi Gracia-Sancho, Zhi-Ren Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab156e8cd1c24f94ba28fcb876a8cb76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rational design of a protein that binds integrin αvβ3 outside the ligand binding site
por: Ravi Chakra Turaga, et al.
Publicado: (2016) -
Early detection and staging of chronic liver diseases with a protein MRI contrast agent
por: Mani Salarian, et al.
Publicado: (2019) -
αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin
por: Mitasha Bharadwaj, et al.
Publicado: (2017) -
The integrin-linked kinase-PINCH-parvin complex supports integrin αIIbβ3 activation.
por: Shigenori Honda, et al.
Publicado: (2013) -
Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis
por: Huaping Chen, et al.
Publicado: (2016)